Translate
Silexion Therapeutics Corp
About
0.43USD+0.01 +2.71%
Closed • Updated at 21:07 GMT+00:00Market Cap$1.79M
Volume1.16M
Beta1.92
RSI38.04
Silexion Therapeutics Corp — investor relations, events, news, and company updates on 6ix.
Latest News
May 26 2026
Silexion Therapeutics Announces 1-for-10 Reverse Share Split
May 18 2026
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 15 2026
Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds
May 14 2026
Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer
May 13 2026
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
Recent Videos
SLXN Stock Analysis | Silexion Therapeutics Corp Stock Latest Chart Update
May 20, 2026
🔥Catch This Hot Stock Early!! May 20, 2026
May 20, 2026
Silexion Therapeutics: My Take on Their Public Offering
Sep 16, 2025
$SLXN Silexion Therapeutics Corp - 60 Second Analysis - September 11, 2025 #SLXN #SILEXION #STOCK
Sep 11, 2025
Community Chat
Ask AI
Try asking